tiprankstipranks
Trending News
More News >
Pharmaron Beijing Co., Ltd. Class H (HK:3759)
FRANKFURT:3759

Compare Pharmaron Beijing Co., Ltd. Class H (3759) vs. Competitors

Compare
10 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Pharmaron Beijing Co., Ltd. Class H
HK$24.14
HK$58.34B
25.02
77.76%
5 Buy
0 Hold
0 Sell
Strong Buy
Genscript Biotech
HK$14.33
HK$31.17B
53.26%
3 Buy
0 Hold
0 Sell
Strong Buy
Zai Lab Ltd
HK$22.18
HK$16.21B
-9.55
-25.21%
5 Buy
2 Hold
0 Sell
Moderate Buy
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$25.16
HK$40.05B
-24.53
134.70%
0 Buy
1 Hold
1 Sell
Moderate Sell
Simcere Pharmaceutical Group Limited
HK$12.15
HK$31.54B
31.48
81.89%
2 Buy
0 Hold
0 Sell
Moderate Buy
Asymchem Laboratories (Tianjin) Co., Ltd. Class H
HK$73.80
HK$40.84B
27.16
82.16%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:3759
Pharmaron Beijing Co., Ltd. Class H
23.18
10.77
86.71%
HK:1548
Genscript Biotech
14.33
5.33
59.22%
HK:9688
Zai Lab Ltd
14.51
-4.85
-25.05%
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
25.16
14.68
140.08%
HK:2096
Simcere Pharmaceutical Group Limited
12.15
5.73
89.25%
HK:6821
Asymchem Laboratories (Tianjin) Co., Ltd. Class H
85.25
39.40
85.93%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts